Business UpdateJul 6, 2026, 08:32 AM
Neuronetics to Participate in B. Riley Securities' Investor Summit
AI Summary
Neuronetics, Inc. announced that its management will participate in the B. Riley Securities' Mind, Muscle & Vision Summit, an invitation-only institutional investor event. The company's management will join a panel discussion titled "Commercializing the Next Wave of Novel Neuropsychiatric Drugs" alongside Compass Pathways on July 16, 2026. Additionally, management will be available for one-on-one meetings with institutional investors throughout the day.
Key Highlights
- Neuronetics management to participate in B. Riley Securities' Mind, Muscle & Vision Summit.
- The event is an invitation-only institutional investor summit held in-person.
- Management will join a panel discussion on "Commercializing the Next Wave of Novel Neuropsychiatric Drugs."
- The panel discussion is scheduled for Thursday, July 16, 2026.
- Neuronetics will participate alongside Compass Pathways on the panel.
- Management will also be available for one-on-one meetings with institutional investors.
Price Impact
More from STIM